Search

Search Constraints

You searched for: Author/Creator Foschi, Francesco Giuseppe

Search Results

1. Application of the Intermediate‐Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma. (January 2016)

2. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (February 2023)

3. Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter. Issue 1 (March 2021)

4. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma. Issue 9 (September 2022)

5. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma. (September 2018)

6. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study. Issue 8 (August 2021)

7. Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study Database. (6th September 2022)

8. Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use. Issue 14 (10th April 2014)

9. Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use. Issue 14 (10th April 2014)

10. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database. Issue 1 (21st December 2021)